Skip to main content
Biohit Oyj logo

Biohit Oyj — Investor Relations & Filings

Ticker · BIOBV ISIN · FI0009005482 LEI · 74370089ATTSNBXJVT29 HE Manufacturing
Open in API
Filings indexed 992 across all filing types
Latest filing 2019-11-29 Report Publication Anno…
Country FI Finland
Listing HE BIOBV

About Biohit Oyj

https://www.biohithealthcare.com/en/

Biohit Oyj is a global biotechnology company that develops, manufactures, and markets innovative diagnostic products and services. The company specializes in tools for the early diagnosis and prevention of diseases, with a primary focus on gastroenterology. Its key offerings include the GastroPanel® blood test for assessing stomach health and screening for risks of gastric cancer, as well as diagnostic tests for conditions such as Helicobacter pylori infection. Operating under the mission "Innovating for Health," Biohit's products are designed to support medical research, facilitate early and accurate diagnosis, and improve patient quality of life.

Recent filings

Filing Released Lang Actions
Biohit Oyj Tulosjulkistamisajankohdat, Biohitin taloudellinen tiedottaminen ja yhtiökokous vuonna 2020
Report Publication Announcement Classification · 98% confidence The document is titled "Biohit Oyj Tulosjulkistamisajankohdat" (Biohit Oyj Earnings Release Dates) and explicitly lists the schedule for future financial announcements, including the 2019 Annual Report release, the Annual General Meeting (AGM) date, and the H1 2020 interim report date. It is not the report itself, but an announcement detailing *when* reports and meetings will occur. This fits the definition of a Report Publication Announcement (RPA), as it announces the timing of future report releases. The document length is short (1573 chars), supporting the 'announcement' classification over the full report classification.
2019-11-29 Finnish
BIOHIT-KONSERNIN PUOLIVUOSIKATSAUS 2019
Interim / Quarterly Report Classification · 100% confidence The document is a 'Puolivuosikatsaus' (Half-year report) for Biohit Oyj for the period of January-June 2019. It contains comprehensive financial statements, including income statements, balance sheets, key performance indicators (KPIs), and management commentary on business performance, R&D, and future outlook. It is a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. H1 2019
2019-08-14 Finnish
BIOHIT-KONSERNIN PUOLIVUOSIKATSAUS 2019
Interim / Quarterly Report Classification · 100% confidence The document is a 'Puolivuosikatsaus' (Half-year report) for Biohit Oyj, covering the period of January to June 2019. It contains comprehensive financial statements, management commentary, key performance indicators, and operational updates. It is not an announcement of a report, but the report itself, containing substantive financial data. Therefore, it is classified as an Interim/Quarterly Report. H1 2019
2019-08-14 Finnish
BIOHIT GROUP HALF YEAR FINANCIAL REPORT 2019
Interim / Quarterly Report Classification · 100% confidence The document is a 'Half Year Financial Report' for Biohit Oyj covering the period January-June 2019. It contains detailed financial statements, including net sales, EBITDA, operating profit/loss, balance sheet data, and management commentary on business performance, R&D, and outlook. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2019
2019-08-14 English
BIOHIT GROUP HALF YEAR FINANCIAL REPORT 2019
Interim / Quarterly Report Classification · 100% confidence The document is a 'Half Year Financial Report' for Biohit Oyj covering the period January-June 2019. It contains comprehensive financial statements, including net sales, EBITDA, operating profit/loss, balance sheet data, and detailed management commentary on business performance, R&D, and outlook. It is a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H2 2019
2019-08-14 English
BIOHIT GROUP HALF YEAR FINANCIAL REPORT 2019
Interim / Quarterly Report Classification · 100% confidence The document is a 'Puolivuosikatsaus' (Half-Year Report) for Biohit Oyj for the period of January-June 2019. It contains comprehensive financial statements, management commentary, key performance indicators, and operational updates. It is a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. H1 2019
2019-08-14 Finnish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.